from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1807/PPE31

LFCtreatmentdescriptionclass of inhibitor

0.964

Amikacinug/mL Amikacintranslation

0.974

Cap5-10ug/mL Capreomycintranslation

2.818

Rox10-50 ug/mL Roxithromycintranslation

0.232

SM2-5 ug/mL Streptomycintranslation

1.498

Tet5-10 ug/mL Tetracyclinetranslation

-0.414

Rif0.2-5ug/mL Rifampicintranscription

-0.260

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.386

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.603

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.509

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.509

Clofazimine10-13 ug/mL Clofaziminerespiration

0.428

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.609

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.150

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.469

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.012

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.261

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.148

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.010

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.151

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.271

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.178

Nigericin50 uM Nigericinrespiration

-0.433

TRC10-150 ug/mL Triclosanrespiration

0.291

TRZ10-25 ug/mL Thioridazinerespiration

1.865

Valinomycin0.5-10 uM Valinomycinrespiration

0.386

ZnSO42 mM ZnSO4respiration

-0.251

menadione6-10 ug/mL Menadionerespiration

-0.081

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.688

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.568

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.766

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.619

NRP_1Non-replicating persistence stage 1dosRassociated

-0.350

Amp0.2mg/mL AmpicillincellWall

-0.388

Cephalexin20-100 ug/mL CephalexincellWall

-0.525

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.144

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.711

EMB10-20 ug/mL EthambutolcellWall

-0.740

Eta12-40 ug/mL EthionamidecellWall

-0.836

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.582

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.972

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.381

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.570

BZA0.12 mg/mL BenzamidearomaticAmides

0.729

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.069

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.925

H2O24 mM hydrogen peroxideDNAdamaging

-0.501

Levo10 ug/mL LevofloxacinDNAdamaging

-0.086

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.975

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.020

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.243

UVUV-irradiationDNAdamaging

-1.627

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.647

Antimycin12.5-50 ug/mL Antimycin A?

-0.702

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.135

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.490

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.498

PA8240.2-2 ug/mL PA-824?

-0.336

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.235

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.047

Verapamil50 uM Verapamil?

-0.723

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.029

methoxatin10-20 ug/mL Methoxatin?